nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—AR—hematologic cancer	0.481	1	CbGaD
Nandrolone decanoate—Progesterone—Prednisolone—hematologic cancer	0.0573	0.535	CrCrCtD
Nandrolone decanoate—Testosterone—Prednisolone—hematologic cancer	0.0498	0.465	CrCrCtD
Nandrolone decanoate—CYP19A1—Betamethasone—hematologic cancer	0.0378	0.632	CbGbCtD
Nandrolone decanoate—CYP19A1—Dexamethasone—hematologic cancer	0.022	0.368	CbGbCtD
Nandrolone decanoate—CYP19A1—ovarian follicle—hematologic cancer	0.0192	0.4	CbGeAlD
Nandrolone decanoate—CYP19A1—hematopoietic system—hematologic cancer	0.00232	0.0483	CbGeAlD
Nandrolone decanoate—MAOB—hematopoietic system—hematologic cancer	0.00219	0.0454	CbGeAlD
Nandrolone decanoate—AR—hematopoietic system—hematologic cancer	0.00206	0.0428	CbGeAlD
Nandrolone decanoate—MAOA—hematopoietic system—hematologic cancer	0.00186	0.0388	CbGeAlD
Nandrolone decanoate—CYP19A1—gonad—hematologic cancer	0.00177	0.0367	CbGeAlD
Nandrolone decanoate—AR—gonad—hematologic cancer	0.00156	0.0325	CbGeAlD
Nandrolone decanoate—CYP19A1—blood—hematologic cancer	0.00154	0.032	CbGeAlD
Nandrolone decanoate—MAOB—blood—hematologic cancer	0.00145	0.0301	CbGeAlD
Nandrolone decanoate—AR—blood—hematologic cancer	0.00136	0.0283	CbGeAlD
Nandrolone decanoate—CYP19A1—testis—hematologic cancer	0.00127	0.0265	CbGeAlD
Nandrolone decanoate—MAOB—lung—hematologic cancer	0.00127	0.0264	CbGeAlD
Nandrolone decanoate—MAOA—blood—hematologic cancer	0.00124	0.0257	CbGeAlD
Nandrolone decanoate—MAOB—testis—hematologic cancer	0.0012	0.0249	CbGeAlD
Nandrolone decanoate—AR—lung—hematologic cancer	0.00119	0.0248	CbGeAlD
Nandrolone decanoate—AR—testis—hematologic cancer	0.00113	0.0234	CbGeAlD
Nandrolone decanoate—MAOA—lung—hematologic cancer	0.00108	0.0225	CbGeAlD
Nandrolone decanoate—MAOA—testis—hematologic cancer	0.00102	0.0212	CbGeAlD
Nandrolone decanoate—CYP19A1—lymph node—hematologic cancer	0.000922	0.0192	CbGeAlD
Nandrolone decanoate—MAOB—lymph node—hematologic cancer	0.000868	0.0181	CbGeAlD
Nandrolone decanoate—AR—lymph node—hematologic cancer	0.000817	0.017	CbGeAlD
Nandrolone decanoate—MAOA—lymph node—hematologic cancer	0.000741	0.0154	CbGeAlD
Nandrolone decanoate—Nandrolone phenpropionate—AR—hematologic cancer	0.000674	0.141	CrCbGaD
Nandrolone decanoate—Ethynodiol—ESR1—hematologic cancer	0.000503	0.105	CrCbGaD
Nandrolone decanoate—Testosterone Propionate—UGT1A1—hematologic cancer	0.000489	0.103	CrCbGaD
Nandrolone decanoate—Norgestimate—ESR1—hematologic cancer	0.000427	0.0897	CrCbGaD
Nandrolone decanoate—Etonogestrel—ESR1—hematologic cancer	0.00037	0.0776	CrCbGaD
Nandrolone decanoate—Testosterone Propionate—AR—hematologic cancer	0.000349	0.0733	CrCbGaD
Nandrolone decanoate—Levonorgestrel—AR—hematologic cancer	0.00034	0.0713	CrCbGaD
Nandrolone decanoate—Levonorgestrel—ESR1—hematologic cancer	0.000262	0.0549	CrCbGaD
Nandrolone decanoate—Pruritus—Clofarabine—hematologic cancer	0.000209	0.00101	CcSEcCtD
Nandrolone decanoate—Pruritus—Daunorubicin—hematologic cancer	0.000209	0.00101	CcSEcCtD
Nandrolone decanoate—Pruritus—Pentostatin—hematologic cancer	0.000209	0.00101	CcSEcCtD
Nandrolone decanoate—Pruritus—Anagrelide—hematologic cancer	0.000209	0.00101	CcSEcCtD
Nandrolone decanoate—Hypertension—Lenalidomide—hematologic cancer	0.000206	0.000996	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Thalidomide—hematologic cancer	0.000205	0.000991	CcSEcCtD
Nandrolone decanoate—Urticaria—Busulfan—hematologic cancer	0.000204	0.000982	CcSEcCtD
Nandrolone decanoate—Oedema—Melphalan—hematologic cancer	0.000201	0.000968	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—hematologic cancer	0.000199	0.00096	CcSEcCtD
Nandrolone decanoate—Urticaria—Procarbazine—hematologic cancer	0.000197	0.000953	CcSEcCtD
Nandrolone decanoate—Pruritus—Teniposide—hematologic cancer	0.000196	0.000944	CcSEcCtD
Nandrolone decanoate—Oedema—Lenalidomide—hematologic cancer	0.000195	0.000941	CcSEcCtD
Nandrolone decanoate—Rash—Methoxsalen—hematologic cancer	0.000195	0.00094	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methoxsalen—hematologic cancer	0.000195	0.000939	CcSEcCtD
Nandrolone decanoate—Urticaria—Dasatinib—hematologic cancer	0.000194	0.000934	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Ifosfamide—hematologic cancer	0.000193	0.000932	CcSEcCtD
Nandrolone decanoate—Oedema—Hydroxyurea—hematologic cancer	0.000192	0.000928	CcSEcCtD
Nandrolone decanoate—Irritability—Dexamethasone—hematologic cancer	0.000192	0.000927	CcSEcCtD
Nandrolone decanoate—Irritability—Betamethasone—hematologic cancer	0.000192	0.000927	CcSEcCtD
Nandrolone decanoate—Hypertension—Bortezomib—hematologic cancer	0.00019	0.000916	CcSEcCtD
Nandrolone decanoate—Rash—Mercaptopurine—hematologic cancer	0.000189	0.000913	CcSEcCtD
Nandrolone decanoate—Dermatitis—Mercaptopurine—hematologic cancer	0.000189	0.000912	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Vincristine—hematologic cancer	0.000188	0.000909	CcSEcCtD
Nandrolone decanoate—Nausea—Nelarabine—hematologic cancer	0.000188	0.000906	CcSEcCtD
Nandrolone decanoate—Rash—Daunorubicin—hematologic cancer	0.000187	0.000901	CcSEcCtD
Nandrolone decanoate—Rash—Clofarabine—hematologic cancer	0.000187	0.000901	CcSEcCtD
Nandrolone decanoate—Dermatitis—Clofarabine—hematologic cancer	0.000186	0.0009	CcSEcCtD
Nandrolone decanoate—Dermatitis—Daunorubicin—hematologic cancer	0.000186	0.0009	CcSEcCtD
Nandrolone decanoate—Rash—Pentostatin—hematologic cancer	0.000186	0.000897	CcSEcCtD
Nandrolone decanoate—Rash—Anagrelide—hematologic cancer	0.000186	0.000897	CcSEcCtD
Nandrolone decanoate—Dermatitis—Pentostatin—hematologic cancer	0.000186	0.000896	CcSEcCtD
Nandrolone decanoate—Dermatitis—Anagrelide—hematologic cancer	0.000186	0.000896	CcSEcCtD
Nandrolone decanoate—Hypertension—Vinorelbine—hematologic cancer	0.000185	0.000895	CcSEcCtD
Nandrolone decanoate—Jaundice—Etoposide—hematologic cancer	0.000184	0.000887	CcSEcCtD
Nandrolone decanoate—Nausea—Methoxsalen—hematologic cancer	0.000184	0.000886	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Irinotecan—hematologic cancer	0.000183	0.000885	CcSEcCtD
Nandrolone decanoate—Urticaria—Chlorambucil—hematologic cancer	0.000183	0.000882	CcSEcCtD
Nandrolone decanoate—Pruritus—Busulfan—hematologic cancer	0.000181	0.000875	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Methotrexate—hematologic cancer	0.000181	0.000872	CcSEcCtD
Nandrolone decanoate—Progesterone—SLC22A1—hematologic cancer	0.000181	0.0379	CrCbGaD
Nandrolone decanoate—Oedema—Bortezomib—hematologic cancer	0.00018	0.000866	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—hematologic cancer	0.000179	0.000865	CcSEcCtD
Nandrolone decanoate—Rash—Idarubicin—hematologic cancer	0.000179	0.000865	CcSEcCtD
Nandrolone decanoate—Dermatitis—Idarubicin—hematologic cancer	0.000179	0.000864	CcSEcCtD
Nandrolone decanoate—Urticaria—Nilotinib—hematologic cancer	0.000179	0.000863	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Gemcitabine—hematologic cancer	0.000179	0.000862	CcSEcCtD
Nandrolone decanoate—Nausea—Mercaptopurine—hematologic cancer	0.000178	0.00086	CcSEcCtD
Nandrolone decanoate—Oedema—Bleomycin—hematologic cancer	0.000178	0.00086	CcSEcCtD
Nandrolone decanoate—Urticaria—Imatinib—hematologic cancer	0.000178	0.000858	CcSEcCtD
Nandrolone decanoate—Hypertension—Thiotepa—hematologic cancer	0.000177	0.000854	CcSEcCtD
Nandrolone decanoate—Pruritus—Procarbazine—hematologic cancer	0.000176	0.000848	CcSEcCtD
Nandrolone decanoate—Nausea—Clofarabine—hematologic cancer	0.000176	0.000848	CcSEcCtD
Nandrolone decanoate—Nausea—Daunorubicin—hematologic cancer	0.000176	0.000848	CcSEcCtD
Nandrolone decanoate—Nausea—Pentostatin—hematologic cancer	0.000175	0.000845	CcSEcCtD
Nandrolone decanoate—Nausea—Anagrelide—hematologic cancer	0.000175	0.000845	CcSEcCtD
Nandrolone decanoate—Urticaria—Cladribine—hematologic cancer	0.000175	0.000843	CcSEcCtD
Nandrolone decanoate—Rash—Teniposide—hematologic cancer	0.000174	0.000841	CcSEcCtD
Nandrolone decanoate—Dermatitis—Teniposide—hematologic cancer	0.000174	0.00084	CcSEcCtD
Nandrolone decanoate—Pruritus—Dasatinib—hematologic cancer	0.000172	0.000832	CcSEcCtD
Nandrolone decanoate—Pruritus—Bexarotene—hematologic cancer	0.000172	0.000832	CcSEcCtD
Nandrolone decanoate—Pruritus—Fludarabine—hematologic cancer	0.000172	0.000829	CcSEcCtD
Nandrolone decanoate—Hypertension—Thalidomide—hematologic cancer	0.000171	0.000826	CcSEcCtD
Nandrolone decanoate—Testosterone—SLC22A1—hematologic cancer	0.000171	0.0358	CrCbGaD
Nandrolone decanoate—Nausea—Idarubicin—hematologic cancer	0.000169	0.000814	CcSEcCtD
Nandrolone decanoate—Irritability—Prednisone—hematologic cancer	0.000167	0.000808	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Cisplatin—hematologic cancer	0.000167	0.000803	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—hematologic cancer	0.000166	0.000801	CcSEcCtD
Nandrolone decanoate—Hypertension—Carmustine—hematologic cancer	0.000165	0.000794	CcSEcCtD
Nandrolone decanoate—Nausea—Teniposide—hematologic cancer	0.000164	0.000792	CcSEcCtD
Nandrolone decanoate—Hypertension—Alitretinoin—hematologic cancer	0.000163	0.000786	CcSEcCtD
Nandrolone decanoate—Pruritus—Chlorambucil—hematologic cancer	0.000163	0.000786	CcSEcCtD
Nandrolone decanoate—Oedema—Thalidomide—hematologic cancer	0.000162	0.000781	CcSEcCtD
Nandrolone decanoate—Rash—Busulfan—hematologic cancer	0.000162	0.000779	CcSEcCtD
Nandrolone decanoate—Dermatitis—Busulfan—hematologic cancer	0.000161	0.000779	CcSEcCtD
Nandrolone decanoate—Hypertension—Ifosfamide—hematologic cancer	0.000161	0.000777	CcSEcCtD
Nandrolone decanoate—Progesterone—AR—hematologic cancer	0.00016	0.0337	CrCbGaD
Nandrolone decanoate—Urticaria—Melphalan—hematologic cancer	0.000159	0.000769	CcSEcCtD
Nandrolone decanoate—Pruritus—Nilotinib—hematologic cancer	0.000159	0.000768	CcSEcCtD
Nandrolone decanoate—Pruritus—Imatinib—hematologic cancer	0.000158	0.000764	CcSEcCtD
Nandrolone decanoate—Hypertension—Vincristine—hematologic cancer	0.000157	0.000758	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—hematologic cancer	0.000157	0.000757	CcSEcCtD
Nandrolone decanoate—Rash—Procarbazine—hematologic cancer	0.000157	0.000756	CcSEcCtD
Nandrolone decanoate—Dermatitis—Procarbazine—hematologic cancer	0.000157	0.000755	CcSEcCtD
Nandrolone decanoate—Pruritus—Cladribine—hematologic cancer	0.000156	0.000751	CcSEcCtD
Nandrolone decanoate—Oedema—Carmustine—hematologic cancer	0.000156	0.00075	CcSEcCtD
Nandrolone decanoate—Urticaria—Lenalidomide—hematologic cancer	0.000155	0.000748	CcSEcCtD
Nandrolone decanoate—Oedema—Alitretinoin—hematologic cancer	0.000154	0.000743	CcSEcCtD
Nandrolone decanoate—Rash—Bexarotene—hematologic cancer	0.000154	0.000741	CcSEcCtD
Nandrolone decanoate—Rash—Dasatinib—hematologic cancer	0.000154	0.000741	CcSEcCtD
Nandrolone decanoate—Dermatitis—Bexarotene—hematologic cancer	0.000153	0.000741	CcSEcCtD
Nandrolone decanoate—Dermatitis—Dasatinib—hematologic cancer	0.000153	0.000741	CcSEcCtD
Nandrolone decanoate—Rash—Fludarabine—hematologic cancer	0.000153	0.000739	CcSEcCtD
Nandrolone decanoate—Dermatitis—Fludarabine—hematologic cancer	0.000153	0.000738	CcSEcCtD
Nandrolone decanoate—Hypertension—Mitoxantrone—hematologic cancer	0.000153	0.000738	CcSEcCtD
Nandrolone decanoate—Hypertension—Irinotecan—hematologic cancer	0.000153	0.000738	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Etoposide—hematologic cancer	0.000153	0.000736	CcSEcCtD
Nandrolone decanoate—Oedema—Ifosfamide—hematologic cancer	0.000152	0.000735	CcSEcCtD
Nandrolone decanoate—Nausea—Busulfan—hematologic cancer	0.000152	0.000734	CcSEcCtD
Nandrolone decanoate—Testosterone—AR—hematologic cancer	0.000152	0.0318	CrCbGaD
Nandrolone decanoate—Hypertension—Gemcitabine—hematologic cancer	0.000149	0.000719	CcSEcCtD
Nandrolone decanoate—Oedema—Vincristine—hematologic cancer	0.000148	0.000716	CcSEcCtD
Nandrolone decanoate—Nausea—Procarbazine—hematologic cancer	0.000148	0.000712	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—hematologic cancer	0.000145	0.000701	CcSEcCtD
Nandrolone decanoate—Nausea—Bexarotene—hematologic cancer	0.000145	0.000698	CcSEcCtD
Nandrolone decanoate—Nausea—Dasatinib—hematologic cancer	0.000145	0.000698	CcSEcCtD
Nandrolone decanoate—Oedema—Mitoxantrone—hematologic cancer	0.000145	0.000698	CcSEcCtD
Nandrolone decanoate—Oedema—Irinotecan—hematologic cancer	0.000145	0.000698	CcSEcCtD
Nandrolone decanoate—Nausea—Fludarabine—hematologic cancer	0.000144	0.000696	CcSEcCtD
Nandrolone decanoate—Urticaria—Bortezomib—hematologic cancer	0.000143	0.000688	CcSEcCtD
Nandrolone decanoate—Pruritus—Melphalan—hematologic cancer	0.000142	0.000685	CcSEcCtD
Nandrolone decanoate—Rash—Nilotinib—hematologic cancer	0.000142	0.000685	CcSEcCtD
Nandrolone decanoate—Dermatitis—Nilotinib—hematologic cancer	0.000142	0.000684	CcSEcCtD
Nandrolone decanoate—Urticaria—Bleomycin—hematologic cancer	0.000142	0.000683	CcSEcCtD
Nandrolone decanoate—Rash—Imatinib—hematologic cancer	0.000141	0.000681	CcSEcCtD
Nandrolone decanoate—Dermatitis—Imatinib—hematologic cancer	0.000141	0.00068	CcSEcCtD
Nandrolone decanoate—Oedema—Gemcitabine—hematologic cancer	0.000141	0.000679	CcSEcCtD
Nandrolone decanoate—Irritability—Methotrexate—hematologic cancer	0.00014	0.000675	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Prednisone—hematologic cancer	0.00014	0.000673	CcSEcCtD
Nandrolone decanoate—Urticaria—Vinorelbine—hematologic cancer	0.000139	0.000672	CcSEcCtD
Nandrolone decanoate—Rash—Cladribine—hematologic cancer	0.000139	0.000669	CcSEcCtD
Nandrolone decanoate—Dermatitis—Cladribine—hematologic cancer	0.000139	0.000668	CcSEcCtD
Nandrolone decanoate—Pruritus—Lenalidomide—hematologic cancer	0.000138	0.000666	CcSEcCtD
Nandrolone decanoate—Nausea—Chlorambucil—hematologic cancer	0.000137	0.00066	CcSEcCtD
Nandrolone decanoate—Nausea—Nilotinib—hematologic cancer	0.000134	0.000645	CcSEcCtD
Nandrolone decanoate—Urticaria—Thiotepa—hematologic cancer	0.000133	0.000642	CcSEcCtD
Nandrolone decanoate—Nausea—Imatinib—hematologic cancer	0.000133	0.000642	CcSEcCtD
Nandrolone decanoate—Oedema—Cisplatin—hematologic cancer	0.000131	0.000633	CcSEcCtD
Nandrolone decanoate—Nausea—Cladribine—hematologic cancer	0.000131	0.00063	CcSEcCtD
Nandrolone decanoate—Urticaria—Thalidomide—hematologic cancer	0.000129	0.000621	CcSEcCtD
Nandrolone decanoate—Hypertension—Etoposide—hematologic cancer	0.000127	0.000614	CcSEcCtD
Nandrolone decanoate—Pruritus—Bortezomib—hematologic cancer	0.000127	0.000613	CcSEcCtD
Nandrolone decanoate—Rash—Melphalan—hematologic cancer	0.000127	0.00061	CcSEcCtD
Nandrolone decanoate—Dermatitis—Melphalan—hematologic cancer	0.000126	0.00061	CcSEcCtD
Nandrolone decanoate—Pruritus—Bleomycin—hematologic cancer	0.000126	0.000608	CcSEcCtD
Nandrolone decanoate—Hypertension—Prednisolone—hematologic cancer	0.000125	0.000605	CcSEcCtD
Nandrolone decanoate—Nausea—Vinblastine—hematologic cancer	0.000125	0.000605	CcSEcCtD
Nandrolone decanoate—Pruritus—Vinorelbine—hematologic cancer	0.000124	0.000598	CcSEcCtD
Nandrolone decanoate—Progesterone—ESR1—hematologic cancer	0.000124	0.0259	CrCbGaD
Nandrolone decanoate—Rash—Lenalidomide—hematologic cancer	0.000123	0.000594	CcSEcCtD
Nandrolone decanoate—Dermatitis—Lenalidomide—hematologic cancer	0.000123	0.000593	CcSEcCtD
Nandrolone decanoate—Urticaria—Alitretinoin—hematologic cancer	0.000122	0.00059	CcSEcCtD
Nandrolone decanoate—Rash—Hydroxyurea—hematologic cancer	0.000121	0.000585	CcSEcCtD
Nandrolone decanoate—Dermatitis—Hydroxyurea—hematologic cancer	0.000121	0.000585	CcSEcCtD
Nandrolone decanoate—Urticaria—Ifosfamide—hematologic cancer	0.000121	0.000584	CcSEcCtD
Nandrolone decanoate—Testosterone—ABCG2—hematologic cancer	0.000119	0.025	CrCbGaD
Nandrolone decanoate—Nausea—Melphalan—hematologic cancer	0.000119	0.000575	CcSEcCtD
Nandrolone decanoate—Oedema—Prednisolone—hematologic cancer	0.000119	0.000572	CcSEcCtD
Nandrolone decanoate—Pruritus—Thiotepa—hematologic cancer	0.000118	0.000571	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Methotrexate—hematologic cancer	0.000117	0.000563	CcSEcCtD
Nandrolone decanoate—Nausea—Lenalidomide—hematologic cancer	0.000116	0.000559	CcSEcCtD
Nandrolone decanoate—Hypertension—Triamcinolone—hematologic cancer	0.000115	0.000557	CcSEcCtD
Nandrolone decanoate—Urticaria—Mitoxantrone—hematologic cancer	0.000115	0.000554	CcSEcCtD
Nandrolone decanoate—Pruritus—Thalidomide—hematologic cancer	0.000115	0.000553	CcSEcCtD
Nandrolone decanoate—Nausea—Hydroxyurea—hematologic cancer	0.000114	0.000551	CcSEcCtD
Nandrolone decanoate—Rash—Bortezomib—hematologic cancer	0.000113	0.000546	CcSEcCtD
Nandrolone decanoate—Dermatitis—Bortezomib—hematologic cancer	0.000113	0.000546	CcSEcCtD
Nandrolone decanoate—Rash—Bleomycin—hematologic cancer	0.000112	0.000542	CcSEcCtD
Nandrolone decanoate—Dermatitis—Bleomycin—hematologic cancer	0.000112	0.000541	CcSEcCtD
Nandrolone decanoate—Rash—Vinorelbine—hematologic cancer	0.000111	0.000533	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vinorelbine—hematologic cancer	0.00011	0.000533	CcSEcCtD
Nandrolone decanoate—Oedema—Triamcinolone—hematologic cancer	0.000109	0.000526	CcSEcCtD
Nandrolone decanoate—Pruritus—Alitretinoin—hematologic cancer	0.000109	0.000526	CcSEcCtD
Nandrolone decanoate—Progesterone—NR3C1—hematologic cancer	0.000109	0.0228	CrCbGaD
Nandrolone decanoate—Pruritus—Ifosfamide—hematologic cancer	0.000108	0.00052	CcSEcCtD
Nandrolone decanoate—Nausea—Bortezomib—hematologic cancer	0.000107	0.000515	CcSEcCtD
Nandrolone decanoate—Nausea—Bleomycin—hematologic cancer	0.000106	0.000511	CcSEcCtD
Nandrolone decanoate—Rash—Thiotepa—hematologic cancer	0.000106	0.000509	CcSEcCtD
Nandrolone decanoate—Dermatitis—Thiotepa—hematologic cancer	0.000105	0.000509	CcSEcCtD
Nandrolone decanoate—Hypertension—Betamethasone—hematologic cancer	0.000105	0.000505	CcSEcCtD
Nandrolone decanoate—Hypertension—Dexamethasone—hematologic cancer	0.000105	0.000505	CcSEcCtD
Nandrolone decanoate—Nausea—Vinorelbine—hematologic cancer	0.000104	0.000502	CcSEcCtD
Nandrolone decanoate—Jaundice—Epirubicin—hematologic cancer	0.000103	0.000497	CcSEcCtD
Nandrolone decanoate—Rash—Thalidomide—hematologic cancer	0.000102	0.000493	CcSEcCtD
Nandrolone decanoate—Dermatitis—Thalidomide—hematologic cancer	0.000102	0.000492	CcSEcCtD
Nandrolone decanoate—Pruritus—Gemcitabine—hematologic cancer	9.96e-05	0.000481	CcSEcCtD
Nandrolone decanoate—Nausea—Thiotepa—hematologic cancer	9.94e-05	0.00048	CcSEcCtD
Nandrolone decanoate—Oedema—Dexamethasone—hematologic cancer	9.9e-05	0.000477	CcSEcCtD
Nandrolone decanoate—Oedema—Betamethasone—hematologic cancer	9.9e-05	0.000477	CcSEcCtD
Nandrolone decanoate—Rash—Carmustine—hematologic cancer	9.81e-05	0.000473	CcSEcCtD
Nandrolone decanoate—Dermatitis—Carmustine—hematologic cancer	9.8e-05	0.000473	CcSEcCtD
Nandrolone decanoate—Rash—Alitretinoin—hematologic cancer	9.71e-05	0.000469	CcSEcCtD
Nandrolone decanoate—Dermatitis—Alitretinoin—hematologic cancer	9.7e-05	0.000468	CcSEcCtD
Nandrolone decanoate—Nausea—Thalidomide—hematologic cancer	9.62e-05	0.000464	CcSEcCtD
Nandrolone decanoate—Rash—Ifosfamide—hematologic cancer	9.6e-05	0.000463	CcSEcCtD
Nandrolone decanoate—Dermatitis—Ifosfamide—hematologic cancer	9.59e-05	0.000463	CcSEcCtD
Nandrolone decanoate—Urticaria—Etoposide—hematologic cancer	9.55e-05	0.000461	CcSEcCtD
Nandrolone decanoate—Jaundice—Doxorubicin—hematologic cancer	9.53e-05	0.00046	CcSEcCtD
Nandrolone decanoate—Norethindrone—ALB—hematologic cancer	9.44e-05	0.0198	CrCbGaD
Nandrolone decanoate—Urticaria—Prednisolone—hematologic cancer	9.42e-05	0.000455	CcSEcCtD
Nandrolone decanoate—Rash—Vincristine—hematologic cancer	9.36e-05	0.000452	CcSEcCtD
Nandrolone decanoate—Dermatitis—Vincristine—hematologic cancer	9.35e-05	0.000451	CcSEcCtD
Nandrolone decanoate—Nausea—Carmustine—hematologic cancer	9.24e-05	0.000446	CcSEcCtD
Nandrolone decanoate—Nausea—Alitretinoin—hematologic cancer	9.15e-05	0.000442	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Methotrexate—hematologic cancer	9.14e-05	0.000441	CcSEcCtD
Nandrolone decanoate—Hypertension—Prednisone—hematologic cancer	9.12e-05	0.00044	CcSEcCtD
Nandrolone decanoate—Rash—Mitoxantrone—hematologic cancer	9.12e-05	0.00044	CcSEcCtD
Nandrolone decanoate—Rash—Irinotecan—hematologic cancer	9.12e-05	0.00044	CcSEcCtD
Nandrolone decanoate—Dermatitis—Mitoxantrone—hematologic cancer	9.11e-05	0.000439	CcSEcCtD
Nandrolone decanoate—Dermatitis—Irinotecan—hematologic cancer	9.11e-05	0.000439	CcSEcCtD
Nandrolone decanoate—Nausea—Ifosfamide—hematologic cancer	9.04e-05	0.000436	CcSEcCtD
Nandrolone decanoate—Norethindrone—ABCB1—hematologic cancer	9.01e-05	0.0189	CrCbGaD
Nandrolone decanoate—Rash—Gemcitabine—hematologic cancer	8.88e-05	0.000428	CcSEcCtD
Nandrolone decanoate—Dermatitis—Gemcitabine—hematologic cancer	8.87e-05	0.000428	CcSEcCtD
Nandrolone decanoate—Nausea—Vincristine—hematologic cancer	8.82e-05	0.000425	CcSEcCtD
Nandrolone decanoate—Urticaria—Triamcinolone—hematologic cancer	8.67e-05	0.000418	CcSEcCtD
Nandrolone decanoate—Oedema—Prednisone—hematologic cancer	8.62e-05	0.000416	CcSEcCtD
Nandrolone decanoate—Nausea—Mitoxantrone—hematologic cancer	8.59e-05	0.000414	CcSEcCtD
Nandrolone decanoate—Nausea—Irinotecan—hematologic cancer	8.59e-05	0.000414	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—hematologic cancer	8.55e-05	0.000413	CcSEcCtD
Nandrolone decanoate—Pruritus—Etoposide—hematologic cancer	8.51e-05	0.00041	CcSEcCtD
Nandrolone decanoate—Nausea—Gemcitabine—hematologic cancer	8.36e-05	0.000404	CcSEcCtD
Nandrolone decanoate—Rash—Cisplatin—hematologic cancer	8.28e-05	0.000399	CcSEcCtD
Nandrolone decanoate—Dermatitis—Cisplatin—hematologic cancer	8.27e-05	0.000399	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—hematologic cancer	7.91e-05	0.000382	CcSEcCtD
Nandrolone decanoate—Urticaria—Dexamethasone—hematologic cancer	7.86e-05	0.000379	CcSEcCtD
Nandrolone decanoate—Urticaria—Betamethasone—hematologic cancer	7.86e-05	0.000379	CcSEcCtD
Nandrolone decanoate—Nausea—Cisplatin—hematologic cancer	7.8e-05	0.000376	CcSEcCtD
Nandrolone decanoate—Pruritus—Triamcinolone—hematologic cancer	7.72e-05	0.000372	CcSEcCtD
Nandrolone decanoate—Rash—Etoposide—hematologic cancer	7.58e-05	0.000366	CcSEcCtD
Nandrolone decanoate—Dermatitis—Etoposide—hematologic cancer	7.58e-05	0.000365	CcSEcCtD
Nandrolone decanoate—Rash—Prednisolone—hematologic cancer	7.48e-05	0.000361	CcSEcCtD
Nandrolone decanoate—Dermatitis—Prednisolone—hematologic cancer	7.47e-05	0.00036	CcSEcCtD
Nandrolone decanoate—Nausea—Etoposide—hematologic cancer	7.14e-05	0.000345	CcSEcCtD
Nandrolone decanoate—Hypertension—Epirubicin—hematologic cancer	7.13e-05	0.000344	CcSEcCtD
Nandrolone decanoate—Nausea—Prednisolone—hematologic cancer	7.05e-05	0.00034	CcSEcCtD
Nandrolone decanoate—Pruritus—Betamethasone—hematologic cancer	7e-05	0.000338	CcSEcCtD
Nandrolone decanoate—Pruritus—Dexamethasone—hematologic cancer	7e-05	0.000338	CcSEcCtD
Nandrolone decanoate—Rash—Triamcinolone—hematologic cancer	6.88e-05	0.000332	CcSEcCtD
Nandrolone decanoate—Dermatitis—Triamcinolone—hematologic cancer	6.87e-05	0.000332	CcSEcCtD
Nandrolone decanoate—Urticaria—Prednisone—hematologic cancer	6.85e-05	0.00033	CcSEcCtD
Nandrolone decanoate—Oedema—Epirubicin—hematologic cancer	6.74e-05	0.000325	CcSEcCtD
Nandrolone decanoate—Hypertension—Doxorubicin—hematologic cancer	6.6e-05	0.000318	CcSEcCtD
Nandrolone decanoate—Nausea—Triamcinolone—hematologic cancer	6.48e-05	0.000313	CcSEcCtD
Nandrolone decanoate—Rash—Dexamethasone—hematologic cancer	6.24e-05	0.000301	CcSEcCtD
Nandrolone decanoate—Rash—Betamethasone—hematologic cancer	6.24e-05	0.000301	CcSEcCtD
Nandrolone decanoate—Oedema—Doxorubicin—hematologic cancer	6.24e-05	0.000301	CcSEcCtD
Nandrolone decanoate—Dermatitis—Dexamethasone—hematologic cancer	6.23e-05	0.000301	CcSEcCtD
Nandrolone decanoate—Dermatitis—Betamethasone—hematologic cancer	6.23e-05	0.000301	CcSEcCtD
Nandrolone decanoate—Pruritus—Prednisone—hematologic cancer	6.1e-05	0.000294	CcSEcCtD
Nandrolone decanoate—Nausea—Dexamethasone—hematologic cancer	5.88e-05	0.000284	CcSEcCtD
Nandrolone decanoate—Nausea—Betamethasone—hematologic cancer	5.88e-05	0.000284	CcSEcCtD
Nandrolone decanoate—Urticaria—Methotrexate—hematologic cancer	5.72e-05	0.000276	CcSEcCtD
Nandrolone decanoate—Rash—Prednisone—hematologic cancer	5.43e-05	0.000262	CcSEcCtD
Nandrolone decanoate—Dermatitis—Prednisone—hematologic cancer	5.43e-05	0.000262	CcSEcCtD
Nandrolone decanoate—Urticaria—Epirubicin—hematologic cancer	5.36e-05	0.000258	CcSEcCtD
Nandrolone decanoate—Progesterone—ABCB1—hematologic cancer	5.25e-05	0.011	CrCbGaD
Nandrolone decanoate—Testosterone—ALB—hematologic cancer	5.2e-05	0.0109	CrCbGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	5.16e-05	0.000561	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HDC—hematologic cancer	5.15e-05	0.00056	CbGpPWpGaD
Nandrolone decanoate—Nausea—Prednisone—hematologic cancer	5.12e-05	0.000247	CcSEcCtD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.11e-05	0.000556	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RPLP1—hematologic cancer	5.11e-05	0.000555	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Methotrexate—hematologic cancer	5.1e-05	0.000246	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—JUN—hematologic cancer	5.08e-05	0.000552	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.04e-05	0.000549	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	5.04e-05	0.000549	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	5.04e-05	0.000548	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HDC—hematologic cancer	5.03e-05	0.000547	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	5.02e-05	0.000546	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ARNTL—hematologic cancer	4.97e-05	0.000541	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	4.97e-05	0.000541	CbGpPWpGaD
Nandrolone decanoate—Testosterone—ABCB1—hematologic cancer	4.96e-05	0.0104	CrCbGaD
Nandrolone decanoate—Urticaria—Doxorubicin—hematologic cancer	4.95e-05	0.000239	CcSEcCtD
Nandrolone decanoate—AR—Gene Expression—NR0B2—hematologic cancer	4.84e-05	0.000526	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CA9—hematologic cancer	4.84e-05	0.000526	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ACP5—hematologic cancer	4.84e-05	0.000526	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EP300—hematologic cancer	4.81e-05	0.000523	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	4.78e-05	0.00052	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOR2—hematologic cancer	4.78e-05	0.000519	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Epirubicin—hematologic cancer	4.77e-05	0.00023	CcSEcCtD
Nandrolone decanoate—MAOA—Metabolism—CDA—hematologic cancer	4.71e-05	0.000513	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	4.69e-05	0.00051	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—EP300—hematologic cancer	4.69e-05	0.00051	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1B—hematologic cancer	4.62e-05	0.000503	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	4.62e-05	0.000502	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—DNMT3A—hematologic cancer	4.62e-05	0.000502	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CASP3—hematologic cancer	4.61e-05	0.000502	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CDA—hematologic cancer	4.6e-05	0.0005	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	4.55e-05	0.000495	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ELL—hematologic cancer	4.55e-05	0.000495	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—IDH1—hematologic cancer	4.55e-05	0.000495	CbGpPWpGaD
Nandrolone decanoate—Rash—Methotrexate—hematologic cancer	4.54e-05	0.000219	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	4.54e-05	0.000494	CbGpPWpGaD
Nandrolone decanoate—Dermatitis—Methotrexate—hematologic cancer	4.54e-05	0.000219	CcSEcCtD
Nandrolone decanoate—MAOA—Metabolism—PC—hematologic cancer	4.54e-05	0.000493	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—TXN—hematologic cancer	4.5e-05	0.000489	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTO1—hematologic cancer	4.5e-05	0.000489	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCC3—hematologic cancer	4.5e-05	0.000489	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	4.5e-05	0.000489	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—JUN—hematologic cancer	4.49e-05	0.000488	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—JUN—hematologic cancer	4.48e-05	0.000487	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CDKN2B—hematologic cancer	4.45e-05	0.000484	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	4.45e-05	0.000484	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	4.44e-05	0.000483	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—AKT1—hematologic cancer	4.44e-05	0.000482	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PC—hematologic cancer	4.42e-05	0.000481	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—hematologic cancer	4.41e-05	0.000213	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—SPHK1—hematologic cancer	4.4e-05	0.000479	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC35B2—hematologic cancer	4.38e-05	0.000476	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GBA—hematologic cancer	4.38e-05	0.000476	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOR2—hematologic cancer	4.37e-05	0.000475	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	4.34e-05	0.000472	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	4.33e-05	0.000471	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	4.32e-05	0.00047	CbGpPWpGaD
Nandrolone decanoate—Nausea—Methotrexate—hematologic cancer	4.28e-05	0.000206	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metabolism—GBA—hematologic cancer	4.27e-05	0.000465	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC35B2—hematologic cancer	4.27e-05	0.000465	CbGpPWpGaD
Nandrolone decanoate—Rash—Epirubicin—hematologic cancer	4.25e-05	0.000205	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—hematologic cancer	4.25e-05	0.000205	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—UGT1A1—hematologic cancer	4.23e-05	0.00046	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.23e-05	0.00046	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NCOR1—hematologic cancer	4.22e-05	0.000459	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—hematologic cancer	4.19e-05	0.000456	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	4.19e-05	0.000455	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	4.18e-05	0.000454	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EP300—hematologic cancer	4.14e-05	0.00045	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—EP300—hematologic cancer	4.13e-05	0.00045	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CRABP1—hematologic cancer	4.11e-05	0.000448	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SLC22A1—hematologic cancer	4.11e-05	0.000448	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	4.09e-05	0.000445	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AGO2—hematologic cancer	4.03e-05	0.000438	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALOX5—hematologic cancer	4.01e-05	0.000436	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTAP—hematologic cancer	4.01e-05	0.000436	CbGpPWpGaD
Nandrolone decanoate—Nausea—Epirubicin—hematologic cancer	4e-05	0.000193	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	3.98e-05	0.000433	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—DNMT3B—hematologic cancer	3.95e-05	0.000429	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—H3F3B—hematologic cancer	3.95e-05	0.000429	CbGpPWpGaD
Nandrolone decanoate—Rash—Doxorubicin—hematologic cancer	3.93e-05	0.00019	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—hematologic cancer	3.93e-05	0.00019	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	3.92e-05	0.000426	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	3.91e-05	0.000426	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CREB1—hematologic cancer	3.91e-05	0.000426	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTAP—hematologic cancer	3.91e-05	0.000425	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NR3C1—hematologic cancer	3.91e-05	0.000425	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NUP98—hematologic cancer	3.88e-05	0.000422	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.88e-05	0.000421	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	3.87e-05	0.000421	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BRAF—hematologic cancer	3.86e-05	0.00042	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—hematologic cancer	3.8e-05	0.000414	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.77e-05	0.00041	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ADCY7—hematologic cancer	3.77e-05	0.00041	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOA3—hematologic cancer	3.77e-05	0.00041	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NUP214—hematologic cancer	3.74e-05	0.000407	CbGpPWpGaD
Nandrolone decanoate—Nausea—Doxorubicin—hematologic cancer	3.7e-05	0.000179	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—MTR—hematologic cancer	3.67e-05	0.000399	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCG2—hematologic cancer	3.67e-05	0.000399	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RPS14—hematologic cancer	3.61e-05	0.000392	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—hematologic cancer	3.61e-05	0.000392	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO2—hematologic cancer	3.6e-05	0.000391	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—FHL2—hematologic cancer	3.57e-05	0.000388	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.57e-05	0.000388	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NUP98—hematologic cancer	3.55e-05	0.000386	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AGRN—hematologic cancer	3.5e-05	0.000381	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—hematologic cancer	3.49e-05	0.000379	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—FHL2—hematologic cancer	3.48e-05	0.000379	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.47e-05	0.000378	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.46e-05	0.000377	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—hematologic cancer	3.44e-05	0.000374	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NUP214—hematologic cancer	3.42e-05	0.000372	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AGRN—hematologic cancer	3.42e-05	0.000372	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SDC1—hematologic cancer	3.41e-05	0.000371	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—hematologic cancer	3.36e-05	0.000365	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	3.33e-05	0.000362	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HMMR—hematologic cancer	3.32e-05	0.000361	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—IDH2—hematologic cancer	3.32e-05	0.000361	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—ESR1—hematologic cancer	3.32e-05	0.000361	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—IDH2—hematologic cancer	3.24e-05	0.000352	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HMMR—hematologic cancer	3.24e-05	0.000352	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MDM2—hematologic cancer	3.24e-05	0.000352	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	3.23e-05	0.000352	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	3.21e-05	0.000349	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—NOTCH1—hematologic cancer	3.21e-05	0.000349	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EIF4EBP1—hematologic cancer	3.15e-05	0.000343	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HSPB1—hematologic cancer	3.15e-05	0.000343	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ARNTL—hematologic cancer	3.12e-05	0.00034	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.07e-05	0.000334	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.05e-05	0.000332	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ARNTL—hematologic cancer	3.04e-05	0.000331	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ACP5—hematologic cancer	3.04e-05	0.00033	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CA9—hematologic cancer	3.04e-05	0.00033	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SMC1A—hematologic cancer	3.02e-05	0.000329	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOR2—hematologic cancer	3e-05	0.000326	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CA9—hematologic cancer	2.96e-05	0.000322	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ACP5—hematologic cancer	2.96e-05	0.000322	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—hematologic cancer	2.96e-05	0.000322	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—H3F3A—hematologic cancer	2.96e-05	0.000322	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.95e-05	0.000321	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOR2—hematologic cancer	2.92e-05	0.000318	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CREBBP—hematologic cancer	2.91e-05	0.000316	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	2.91e-05	0.000316	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NQO1—hematologic cancer	2.9e-05	0.000315	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CD44—hematologic cancer	2.9e-05	0.000315	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—IDH1—hematologic cancer	2.86e-05	0.000311	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.85e-05	0.00031	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EZH2—hematologic cancer	2.84e-05	0.000309	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—TXN—hematologic cancer	2.82e-05	0.000307	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCC3—hematologic cancer	2.82e-05	0.000307	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTO1—hematologic cancer	2.82e-05	0.000307	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—IDH1—hematologic cancer	2.78e-05	0.000303	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PARP1—hematologic cancer	2.78e-05	0.000302	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SPHK1—hematologic cancer	2.76e-05	0.0003	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCC3—hematologic cancer	2.75e-05	0.000299	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTO1—hematologic cancer	2.75e-05	0.000299	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—TXN—hematologic cancer	2.75e-05	0.000299	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYCS—hematologic cancer	2.74e-05	0.000298	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HSP90AA1—hematologic cancer	2.73e-05	0.000296	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—hematologic cancer	2.71e-05	0.000294	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SPHK1—hematologic cancer	2.69e-05	0.000293	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HDAC2—hematologic cancer	2.68e-05	0.000292	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—UGT1A1—hematologic cancer	2.65e-05	0.000289	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—UGT1A1—hematologic cancer	2.59e-05	0.000282	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SLC22A1—hematologic cancer	2.58e-05	0.000281	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CRABP1—hematologic cancer	2.58e-05	0.000281	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CRABP1—hematologic cancer	2.52e-05	0.000274	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SLC22A1—hematologic cancer	2.52e-05	0.000274	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALOX5—hematologic cancer	2.52e-05	0.000274	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	2.5e-05	0.000272	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALOX5—hematologic cancer	2.45e-05	0.000267	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NUP98—hematologic cancer	2.44e-05	0.000265	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—hematologic cancer	2.42e-05	0.000263	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.41e-05	0.000262	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NUP98—hematologic cancer	2.38e-05	0.000259	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ADCY7—hematologic cancer	2.37e-05	0.000257	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOA3—hematologic cancer	2.37e-05	0.000257	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NUP214—hematologic cancer	2.35e-05	0.000255	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.32e-05	0.000252	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ADCY7—hematologic cancer	2.31e-05	0.000251	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOA3—hematologic cancer	2.31e-05	0.000251	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCG2—hematologic cancer	2.3e-05	0.00025	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTR—hematologic cancer	2.3e-05	0.00025	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NUP214—hematologic cancer	2.29e-05	0.000249	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ABCB1—hematologic cancer	2.29e-05	0.000249	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.27e-05	0.000247	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO2—hematologic cancer	2.26e-05	0.000245	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCG2—hematologic cancer	2.24e-05	0.000244	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTR—hematologic cancer	2.24e-05	0.000244	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTM1—hematologic cancer	2.22e-05	0.000242	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NCOR1—hematologic cancer	2.22e-05	0.000242	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO2—hematologic cancer	2.2e-05	0.000239	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—hematologic cancer	2.19e-05	0.000238	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CDKN2B—hematologic cancer	2.14e-05	0.000233	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—SDC1—hematologic cancer	2.14e-05	0.000233	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—hematologic cancer	2.14e-05	0.000232	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.1e-05	0.000229	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SDC1—hematologic cancer	2.09e-05	0.000227	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NCOR1—hematologic cancer	2.03e-05	0.000221	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.99e-05	0.000217	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.97e-05	0.000214	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—MTHFR—hematologic cancer	1.96e-05	0.000214	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.88e-05	0.000205	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NR3C1—hematologic cancer	1.88e-05	0.000205	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CD44—hematologic cancer	1.82e-05	0.000198	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NQO1—hematologic cancer	1.82e-05	0.000198	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—HRAS—hematologic cancer	1.78e-05	0.000193	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CD44—hematologic cancer	1.77e-05	0.000193	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NQO1—hematologic cancer	1.77e-05	0.000193	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.74e-05	0.000189	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—hematologic cancer	1.72e-05	0.000188	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYCS—hematologic cancer	1.72e-05	0.000187	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HSP90AA1—hematologic cancer	1.71e-05	0.000186	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYCS—hematologic cancer	1.68e-05	0.000183	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HSP90AA1—hematologic cancer	1.67e-05	0.000181	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CG—hematologic cancer	1.65e-05	0.000179	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MAPK14—hematologic cancer	1.63e-05	0.000177	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ESR1—hematologic cancer	1.6e-05	0.000174	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NOTCH1—hematologic cancer	1.54e-05	0.000168	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CREBBP—hematologic cancer	1.53e-05	0.000166	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—hematologic cancer	1.52e-05	0.000165	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.5e-05	0.000163	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—hematologic cancer	1.48e-05	0.000161	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CD—hematologic cancer	1.45e-05	0.000158	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ABCB1—hematologic cancer	1.44e-05	0.000156	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALB—hematologic cancer	1.43e-05	0.000156	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.43e-05	0.000156	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ABCB1—hematologic cancer	1.4e-05	0.000152	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CREBBP—hematologic cancer	1.4e-05	0.000152	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NCOR1—hematologic cancer	1.39e-05	0.000152	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTM1—hematologic cancer	1.39e-05	0.000152	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3R1—hematologic cancer	1.37e-05	0.000149	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NCOR1—hematologic cancer	1.36e-05	0.000148	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTM1—hematologic cancer	1.36e-05	0.000148	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CB—hematologic cancer	1.26e-05	0.000138	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—MTHFR—hematologic cancer	1.23e-05	0.000134	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—MTHFR—hematologic cancer	1.2e-05	0.000131	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTEN—hematologic cancer	1.09e-05	0.000119	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.06e-05	0.000115	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—EP300—hematologic cancer	1.04e-05	0.000113	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CG—hematologic cancer	1.04e-05	0.000113	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CG—hematologic cancer	1.01e-05	0.00011	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CREBBP—hematologic cancer	9.6e-06	0.000104	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CREBBP—hematologic cancer	9.36e-06	0.000102	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CD—hematologic cancer	9.1e-06	9.9e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALB—hematologic cancer	8.98e-06	9.77e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CD—hematologic cancer	8.88e-06	9.66e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALB—hematologic cancer	8.76e-06	9.53e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3R1—hematologic cancer	8.59e-06	9.35e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MAPK3—hematologic cancer	8.54e-06	9.29e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3R1—hematologic cancer	8.38e-06	9.12e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—hematologic cancer	8.3e-06	9.03e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CB—hematologic cancer	7.93e-06	8.63e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CB—hematologic cancer	7.74e-06	8.42e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PIK3CA—hematologic cancer	7.71e-06	8.38e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTEN—hematologic cancer	6.86e-06	7.46e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTEN—hematologic cancer	6.69e-06	7.27e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—EP300—hematologic cancer	6.54e-06	7.11e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—EP300—hematologic cancer	6.38e-06	6.94e-05	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—AKT1—hematologic cancer	6.3e-06	6.85e-05	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—AKT1—hematologic cancer	5.76e-06	6.26e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PIK3CA—hematologic cancer	4.84e-06	5.26e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PIK3CA—hematologic cancer	4.72e-06	5.13e-05	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—AKT1—hematologic cancer	3.95e-06	4.3e-05	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—AKT1—hematologic cancer	3.85e-06	4.19e-05	CbGpPWpGaD
